|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Human medicine
|
|
Name of medicinal product:
|
EURARTESIM
|
|
Active substances:
|
|
|
ATC code:
|
P01BF05
|
|
Dosage form:
|
film-coated tablet
|
|
Strength:
|
40mg+320mg
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Indication:
|
Eurartesim is indicated for the treatment of uncomplicated Plasmodium falciparum malaria in adults,
adolescents, children and infants 6 months and over and weighing 5 kg or more.
Consideration should be given to official guidance on the appropriate use of antimalarial medicinal
products, including information on the prevalence of resistance to artenimol/piperaquine in the
geographical region where the infection was acquired (see section 4.4).
|
|
Safety features:
|
Yes
|
|
Marketing authorization holder:
|
Alfasigma S.p.A.
|
|
Marketing authorization number:
|
EU/1/11/716
|
|
Marketing authorization issued on:
|
October 27, 2011
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1546714
|
EURARTESIM
|
film-coated tablet
|
40mg +320mg 3TK
|
Prescription
|
|
|
|
|
|
|
1546725
|
EURARTESIM
|
film-coated tablet
|
40mg +320mg 6TK
|
Prescription
|
|
|
|
|
|
|
1546736
|
EURARTESIM
|
film-coated tablet
|
40mg +320mg 9TK
|
Prescription
|
|
|
|
|
|
|
1546747
|
EURARTESIM
|
film-coated tablet
|
40mg +320mg 12TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere